News
Videos
Conferences
Events
Resources
Subscribe

|Articles|April 20, 2017

Risk Factors and More: A Roundup of This Week's #CureFact Snippets

Author(s)CURE staff

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Matthew Matasar

Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer

October 21st 2025

head and neck cancer

Buparlisib Plus Chemo Fails to Improve Head and Neck Cancer Survival

October 21st 2025

In patients with operable, newly diagnosed brain metastases, GammaTile was associated with reduction in the risk of tumor recurrence or death.

GammaTile May Reduce Risk of Brain Tumor Recurrence or Death

October 21st 2025

Image of females.

Breast Cancer Survivors Share Advice for Newly Diagnosed Patients

ByMaureen Green,Silvia Davis

October 21st 2025

VCN-01 plus standard chemotherapy and Abraxane proved safe and effective for patients with metastatic pancreatic cancer.

VCN-01 with Standard Care Boosts Survival, Shows Safety in PDAC

October 20th 2025

Trending on CURE

Trodelvy Plus Keytruda Upholds Quality of Life in TNBC

ADC Use Rapidly Growing in Metastatic Breast Cancer Treatment

Cancer Vaccine Plus Keytruda Slow Advanced Melanoma Progression

Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer

Camrelizumab Combo Extends Survival in Metastatic Cervical Cancer

© 2025 MJH Life Sciences^®

All rights reserved.